Free Newsletter
Gene atlas helps find new therapies
Allen Institute for Brain Science has begun to unveil the Allen Spinal Cord Atlas, a free resource that will eventually show how a mouse's full set of 20,000 genes influences spinal-cord development, pointing researchers to new therapies.
"The Allen Spinal Cord Atlas offers profound potential for researchers to unlock the mysteries of the spinal cord and how it is altered during disease or injury," Allan Jones, chief scientific officer at the Seattle-based Allen Institute for Brain Science, said in a statement
- read the story from MSNBC
Related Article:
Gene therapy advance a better way to target genes
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: